Skip to main content
Howard B. Goldman

Howard B. Goldman

🇺🇸 United States🏥 Cleveland ClinicMD

Training and career​

  • Medical school Albert Einstein College of Medicine (attended)1
  • Residency University of Tennessee Health Sciences Center1
  • Fellowship Female urology, Cleveland Clinic21
  • Leadership Director, urogynecology and reconstructive pelvic surgery fellowship, Cleveland Clinic's Glickman Urological and Kidney Institute3

Key Publications​

His cited chapters and article address transabdominal and transvaginal vesicovaginal fistula repair and urethrovaginal closure. His studies also examine sacral neuromodulation screening, programming, and lumbosacral MRI in patients with an implanted device.P3P4P5P6P7

  1. Goldman HB, Lloyd JC, Noblett KL, et al. "International Continence Society best practice statement for use of sacral neuromodulation." Neurourology and Urodynamics. 2018;37(5):1823–1848. doi

    ICS sacral neuromodulation best practice statement (2018). Led an International Continence Society panel addressing patient selection, implantation, follow-up and troubleshooting for sacral neuromodulation.

  2. Frainey BT, Majerus SJA, Derisavifard S, et al. "First in Human Subjects Testing of the UroMonitor: A Catheter-free Wireless Ambulatory Bladder Pressure Monitor." J Urol. 2023;210(1):186–195. doi

    Catheter-free UroMonitor bladder pressure study (2023). Led clinical testing of a wireless intravesical pressure sensor in 11 women undergoing evaluation for overactive bladder symptoms.

  3. Tenggardjaja CF, Goldman HB. Transabdominal Vesicovaginal and Vesicouterine Fistula Repair. In: Cardozo L, Staskin D, eds. Textbook of Female Urology and Urogynecology. Vol 2: Surgical Perspectives. 5th ed. CRC Press; 2023:1152-1159.
  4. Clifton M, Goldman HB. Transvaginal Repair of Vesicovaginal Fistula. In: Smith JA Jr, Dmochowski RR, Thomas JC, Preminger GM, eds. Hinman's Atlas of Urologic Surgery. 5th ed. Elsevier; 2025:439-444.
  5. Kocher NJ, Derisavifard S, Rueb J, Goldman HB. "Predictive Factors of PNE Success in a Contemporary Series: A Single Institution Experience." Neurourol Urodyn. 2021;40(1):376-383. doi
  6. Rueb J, Fascelli M, Goldman HB, et al. "The Role of Pulse Width Manipulation Compared to Program Changes Alone for Unsatisfactory Sacral Neuromodulation Therapy." Neurourol Urodyn. 2021;40(1):522-528. doi
  7. Guzman-Negron JM, Pizarro-Berdichevsky J, Gill BC, Goldman HB. Can Lumbosacral Magnetic Resonance Imaging Be Performed Safely in Patients With a Sacral Neuromodulation Device? An In Vivo Prospective Study. The Journal of Urology. 2018;200(5):1088-1092. doi

Other Publications Cited on WARWIKI

15 additional publications with Howard B. Goldman as a listed author are cited on WARWIKI, ordered by the number of pages that cite them. Papers whose author list is shortened to "et al." before this name are not included.

  1. Zillioux J, Welk B, Suskind AM, Gormley EA, Goldman HB. "SUFU white paper on overactive bladder anticholinergic medications and dementia risk." Neurourol Urodyn. 2022;41(8):1928-1933. doi
  2. Gleich LD, Goldman HB. "Urethrolysis." Neurourol Urodyn. 2025;44(1):76–84. doi
    Cited on: Mayo Scissors
  3. Trump T, Anis O, Goldman HB, Chow PM. "Outcomes of Sacral Neuromodulation and Intradetrusor Onabotulinum Toxin in the Management of Stroke Associated Urinary Incontinence." Int Neurourol J. 2025;29(1):10–16. doi
  4. Kaufman MR, Goldman HB, Chermansky CJ, et al. Iltamiocel Autologous Cell Therapy for the Treatment of Female Stress Urinary Incontinence: A Double-Blind, Randomized, Stratified, Placebo-Controlled Trial. Neurourol Urodyn. 2024;43:2290–2299. doi
  5. Hickman LC, Paraiso MFR, Goldman HB, Propst K, Ferrando CA. Same-day discharge after minimally invasive sacrocolpopexy is feasible, safe, and associated with high patient satisfaction. Female Pelvic Med Reconstr Surg. 2021;27(8):e614-e619. doi
    Cited on: Sacrocolpopexy
  6. Clifton MM, Goldman HB. "Urethrovaginal fistula closure." Int Urogynecol J. 2017;28(1):157–158. doi
  7. King AB, Goldman HB. Pain related to transvaginal mesh placed for stress urinary incontinence and pelvic organ prolapse. In: Goldman HB, ed. Complications of Female Incontinence and Pelvic Reconstructive Surgery. 2nd ed. Springer (Humana Press); 2017:145–154. doi
  8. Abraham N, Goldman HB. "An update on the pharmacotherapy for lower urinary tract dysfunction." Expert Opin Pharmacother. 2015;16(1):79–93. doi
  9. Crescenze IM, Goldman HB. "Female urethral diverticulum: current diagnosis and management." Curr Urol Rep. 2015;16(10):71. doi
  10. Zyczynski HM, Albo ME, Goldman HB, Wai CY, Sirls LT, Brubaker L, et al. Change in overactive bladder symptoms after surgery for stress urinary incontinence in women. Obstet Gynecol. 2015;126(2):423-430. doi
  11. King AB, Goldman HB. "Bladder Outlet Obstruction in Women: Functional Causes." Curr Urol Rep. 2014;15(9):436. doi
  12. Firoozi F, Goldman HB. Transvaginal excision of mesh erosion involving the bladder after mesh placement using a prolapse kit: a novel technique. Urology. 2010;75(1):203–206. doi

Footnotes​

  1. Dr. Howard Goldman, MD. Request Appoin. Accessed October 2026. ↩ ↩2 ↩3

  2. Meet Our Members. Accessed October 2026. ↩

  3. Urogynecology and Reconstructive Pelvic Surgery Fellowship. Cleveland Clinic. Accessed October 2026. ↩